Buratuss 7.5 mg/5 ml (Syrup)

Indications

• Relieves dry (non-productive) cough
• Used for pre & post-operative cough sedation
• Relief of cough due to acute lower respiratory tract infections

Pharmacology

• Butamirate Citrate acts directly on the brain's cough center to suppress cough
• Safe and non-sedating
• Rapid and complete absorption after oral administration

Dosage & Administration

• For adults: 2-3 tablets of Butamirate Citrate 50 mg daily
• For children (3-6 yrs): 5 ml of syrup 3 times daily
• For adolescents over 12 years old: 1-2 tablets of Butamirate Citrate 50 mg daily

Interaction

• Concomitant use with expectorants should be avoided

Contraindications

• Hypersensitivity to the active ingredient

Side Effects

• Good tolerance observed
• Adverse reactions such as rash, nausea, and diarrhea in rare cases

Pregnancy & Lactation

• Not recommended during the first trimester of pregnancy
• Caution advised during the remainder of pregnancy
• Carefully weigh the benefits against the risks during breastfeeding

Precautions & Warnings

• Avoid concomitant use with expectorants to prevent mucus retention
• Consult a doctor if cough persists for more than 7 days

Overdose Effects

• Symptoms may include drowsiness, nausea, vomiting, and hypotension
• Standard emergency procedures should be followed

Therapeutic Class

• Cough suppressant

Storage Conditions

• Keep away from light and moisture
• Store below 30°C
• Keep out of the reach of children

Related Brands

• Bucod SR 50 mg (Tablet (Sustained Release)) - sharif-pharmaceuticals-ltd
• Bukof 50 mg (Tablet (Sustained Release)) - beacon-pharmaceuticals-plc
• Deconil SR 50 mg (Tablet (Sustained Release)) - orion-pharma-ltd
• Kofnix SR 50 mg (Tablet (Sustained Release)) - aci-limited
• Mirakof SR 50 mg (Tablet (Sustained Release)) - square-pharmaceuticals-plc